Standard
Association between age, IL-10, IFN¿, stimulated C-peptide and disease progression in children with newly diagnosed Type 1 diabetes. / Kaas, A; Pfleger, Claudia Christina; Kharagjitsingh, A V; Schloot, N C; Hansen, L; Buschard, K; Koeleman, B P C; Roep, B O; Mortensen, H B; Alizadeh, B Z; Hvidoere Study Group On Childhood Diabetes ; Mandrup-Poulsen, Thomas.
In:
Diabetic Medicine Online, Vol. 29, No. 6, 2012, p. 734-741.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Kaas, A, Pfleger, CC, Kharagjitsingh, AV, Schloot, NC, Hansen, L, Buschard, K, Koeleman, BPC, Roep, BO, Mortensen, HB, Alizadeh, BZ, Hvidoere Study Group On Childhood Diabetes
& Mandrup-Poulsen, T 2012, '
Association between age, IL-10, IFN¿, stimulated C-peptide and disease progression in children with newly diagnosed Type 1 diabetes',
Diabetic Medicine Online, vol. 29, no. 6, pp. 734-741.
https://doi.org/10.1111/j.1464-5491.2011.03544.xAPA
Kaas, A., Pfleger, C. C., Kharagjitsingh, A. V., Schloot, N. C., Hansen, L., Buschard, K., Koeleman, B. P. C., Roep, B. O., Mortensen, H. B., Alizadeh, B. Z., Hvidoere Study Group On Childhood Diabetes
, & Mandrup-Poulsen, T. (2012).
Association between age, IL-10, IFN¿, stimulated C-peptide and disease progression in children with newly diagnosed Type 1 diabetes.
Diabetic Medicine Online,
29(6), 734-741.
https://doi.org/10.1111/j.1464-5491.2011.03544.xVancouver
Kaas A, Pfleger CC, Kharagjitsingh AV, Schloot NC, Hansen L, Buschard K et al.
Association between age, IL-10, IFN¿, stimulated C-peptide and disease progression in children with newly diagnosed Type 1 diabetes.
Diabetic Medicine Online. 2012;29(6):734-741.
https://doi.org/10.1111/j.1464-5491.2011.03544.xAuthor
Kaas, A ; Pfleger, Claudia Christina ; Kharagjitsingh, A V ; Schloot, N C ; Hansen, L ; Buschard, K ; Koeleman, B P C ; Roep, B O ; Mortensen, H B ; Alizadeh, B Z ; Hvidoere Study Group On Childhood Diabetes ; Mandrup-Poulsen, Thomas. / Association between age, IL-10, IFN¿, stimulated C-peptide and disease progression in children with newly diagnosed Type 1 diabetes. In: Diabetic Medicine Online. 2012 ; Vol. 29, No. 6. pp. 734-741.
Bibtex
@article{967ed5bddd6a4e3f8e7f55d7cb064a11,
title = "Association between age, IL-10, IFN¿, stimulated C-peptide and disease progression in children with newly diagnosed Type 1 diabetes",
abstract = "Aims: The relation of disease progression and age, serum interleukin 10 (IL-10) and interferon gamma (IFN¿) and their genetic correlates were studied in paediatric patients with newly diagnosed Type 1 diabetes. Methods: Two hundred and twenty-seven patients from the Hvidoere Study Group were classified in four different progression groups as assessed by change in stimulated C-peptide from 1 to 6 months. CA repeat variants of the IL-10 and IFN¿ gene were genotyped and serum levels of IL-10 and IFN¿ were measured at 1, 6 and 12 months. Results: IL-10 decreased (P ",
author = "A Kaas and Pfleger, {Claudia Christina} and Kharagjitsingh, {A V} and Schloot, {N C} and L Hansen and K Buschard and Koeleman, {B P C} and Roep, {B O} and Mortensen, {H B} and Alizadeh, {B Z} and {Hvidoere Study Group On Childhood Diabetes} and Thomas Mandrup-Poulsen",
note = "{\textcopyright} 2011 The Authors. Diabetic Medicine {\textcopyright} 2011 Diabetes UK.",
year = "2012",
doi = "10.1111/j.1464-5491.2011.03544.x",
language = "English",
volume = "29",
pages = "734--741",
journal = "Diabetic Medicine Online",
issn = "1464-5491",
publisher = "Wiley-Blackwell",
number = "6",
}
RIS
TY - JOUR
T1 - Association between age, IL-10, IFN¿, stimulated C-peptide and disease progression in children with newly diagnosed Type 1 diabetes
AU - Kaas, A
AU - Pfleger, Claudia Christina
AU - Kharagjitsingh, A V
AU - Schloot, N C
AU - Hansen, L
AU - Buschard, K
AU - Koeleman, B P C
AU - Roep, B O
AU - Mortensen, H B
AU - Alizadeh, B Z
AU - Hvidoere Study Group On Childhood Diabetes
AU - Mandrup-Poulsen, Thomas
N1 - © 2011 The Authors. Diabetic Medicine © 2011 Diabetes UK.
PY - 2012
Y1 - 2012
N2 - Aims: The relation of disease progression and age, serum interleukin 10 (IL-10) and interferon gamma (IFN¿) and their genetic correlates were studied in paediatric patients with newly diagnosed Type 1 diabetes. Methods: Two hundred and twenty-seven patients from the Hvidoere Study Group were classified in four different progression groups as assessed by change in stimulated C-peptide from 1 to 6 months. CA repeat variants of the IL-10 and IFN¿ gene were genotyped and serum levels of IL-10 and IFN¿ were measured at 1, 6 and 12 months. Results: IL-10 decreased (P
AB - Aims: The relation of disease progression and age, serum interleukin 10 (IL-10) and interferon gamma (IFN¿) and their genetic correlates were studied in paediatric patients with newly diagnosed Type 1 diabetes. Methods: Two hundred and twenty-seven patients from the Hvidoere Study Group were classified in four different progression groups as assessed by change in stimulated C-peptide from 1 to 6 months. CA repeat variants of the IL-10 and IFN¿ gene were genotyped and serum levels of IL-10 and IFN¿ were measured at 1, 6 and 12 months. Results: IL-10 decreased (P
U2 - 10.1111/j.1464-5491.2011.03544.x
DO - 10.1111/j.1464-5491.2011.03544.x
M3 - Journal article
C2 - 22150609
VL - 29
SP - 734
EP - 741
JO - Diabetic Medicine Online
JF - Diabetic Medicine Online
SN - 1464-5491
IS - 6
ER -
